About Cellbox Labs
Cellbox Labs is a company based in Riga (Latvia) founded in 2020. Cellbox Labs has raised $1.01 million across 2 funding rounds from investors including LatBAN and Buildit. The company has 10 employees. Cellbox Labs offers products and services including Vascularized Organ-on-Chip Platform, Gut-Brain-Axis-on-Chip, and Primary Cell Gut-on-Chip Model. Cellbox Labs operates in a competitive market with competitors including Emulate, CN Bio, AxoSim, Mimetas and Nortis, among others.
- Headquarter Riga, Latvia
- Employees 10
- SectorsHealthcare
- Website cellboxlabs.com
- Social LinkedIn
- Legal Name Cellboxlab
- Annual Revenue$394.12 K (USD)12as on Dec 31, 2023
- Net Profit-$101.94 K (USD)-215as on Dec 31, 2023
- Total Equity Funding$1.01M (USD)
in 2 rounds
- Latest Funding Round$3.85M (USD), Grant
Aug 2025
- InvestorsLatBAN
& 1 more
- Employee Count10
Products & Services of Cellbox Labs
Cellbox Labs offers a comprehensive portfolio of products and services, including Vascularized Organ-on-Chip Platform, Gut-Brain-Axis-on-Chip, and Primary Cell Gut-on-Chip Model.
Hardware-software system for precise drug testing and experiment design.
Platform accelerating research on gut-brain interactions for drug development.
Tool evaluating medication effects on intestinal stem cells in simulated environments.
Funding Insights of Cellbox Labs
Cellbox Labs has successfully raised a total of $1.01M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $3.85 million completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.01M
- Total Rounds 2
- Last Round Grant — $3.85M
- First Round $1.01M
(May 2024)
- Investors Count 2
All 2 funding rounds of Cellbox Labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in Cellbox Labs
Cellbox Labs has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include LatBAN and Buildit.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
IOT startups are accelerated by Buildit in Latvia's ecosystem. | 2013 | buildit.lv | Riga, Latvia | |
Angel investors are connected with businesses seeking funding. | 2014 | latban.lv | Riga, Latvia |
Investor details for Cellbox Labs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cellbox Labs
1 people are tracked at Cellbox Labs (1 in leadership); the tracked headcount is 10.
| Name | Role | Group |
|---|---|---|
Roberts Rimsa | CTO & Co-founder | Leadership |
Complete people profiles for Cellbox Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cellbox Labs
3 dated milestones of Cellbox Labs across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Cellbox Labs is founded.
- Funding First funding round of $1.0M.
- Funding Latest funding round, Grant, of $3.8M.
Competitors of Cellbox Labs
Cellbox Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Emulate, CN Bio, AxoSim, Mimetas and Nortis, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| emulatebio.com | 2013 | Boston, United States | $204.49M | 93 | Developer of in vitro models for drug development | |
| cn-bio.com | 2009 | Cambridge, United Kingdom | $44.78M | 33 | Organ-on-a-chip platforms are developed for drug discovery applications. | |
| axosim.com | 2014 | New Orleans, United States | $6.78M | 27 | Nerve-on-a-chip technology is advanced by AxoSim for drug development improvement. | |
| mimetas.com | 2013 | Leiden, Netherlands | $28.9M | – | Microfluidics-based organ-on-a-chip models for drug evaluation are developed. | |
| nortisbio.com | 2007 | Woodinville, United States | $10.66M | 19 | Small human tissue segments are generated in microfluidic chips. | |
| netri.com | 2018 | Lyon, France | $8.89M | – | Microfluidic devices are developed for industrial applications and brain-on-a-chip models. | |
| mepsgen.com | 2019 | Seoul, South Korea | $29.26M | – | Developer of human organ model chips for pharmaceutical development | |
| obatalasciences.com | 2017 | New Orleans, United States | $3.54M | 10 | Provider of research enabling products and services to research centers | |
| hesperosinc.com | 2015 | Orlando, United States | – | 15 | Organ-on-a-chip solutions for preclinical testing are developed. |
Detailed competitors of Cellbox Labs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cellbox Labs
Complete news archive for Cellbox Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Cellbox Labs
10 companies that operate in the same segment as Cellbox Labs (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cellbox Labs
Cellbox Labs was founded in 2020 and raised its 1st funding round 4 years after it was founded.
Cellbox Labs is headquartered in Riga, Latvia.
Cellbox Labs is a funded company, having raised a total of $1.01M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.01M, raised on May 2024.
Cellbox Labs has 10 employees.
Annual revenue of Cellbox Labs is $394.12K as on Dec 31, 2023.
Cellbox Labs offers Vascularized Organ-on-Chip Platform, Gut-Brain-Axis-on-Chip, Primary Cell Gut-on-Chip Model while focusing on life sciences, life sciences platforms and tools, instruments, microfluidics, and organ on a chip. Provider of organ-on-chip platform for drug discovery and development. Delivering reliable solutions, it emphasizes quality, efficiency, and meeting diverse client needs.
Cellbox Labs offers Vascularized Organ-on-Chip Platform, Gut-Brain-Axis-on-Chip, and Primary Cell Gut-on-Chip Model.
Cellbox Labs operates through Cellboxlab.